Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Goldman Sachs
Biotech
AirNexis swoops in with $200M series A for COPD asset
AirNexis has inked a deal potentially worth almost $1 billion with a China biopharma, securing rights to a clinical-stage COPD asset.
Gabrielle Masson
Jan 9, 2026 11:01am
BMS taps biotech analyst to lead long-term strategy
Jun 13, 2025 11:11am
Newleos unveils with $93M and 4 ex-Roche programs
Feb 13, 2025 12:00am
I&I biotech Triveni raises $115M for preclinical antibodies
Oct 2, 2024 7:00am
Goldman Sachs closes $650M fund aimed at biotechs
Jan 3, 2024 10:06am
Moma Therapeutics raises $150M for precision cancer medicines
May 10, 2022 7:00am
